Literature DB >> 23904451

Dyna-CT-assisted percutaneous microballoon compression for trigeminal neuralgia.

Xiaochuan Huo1, Xiaoyun Sun2, Zhenxing Zhang2, Wenshi Guo2, Ning Guan2, Junsheng Luo1.   

Abstract

BACKGROUND: Percutaneous microballoon compression (PMC) for trigeminal neuralgia (TN) is a well-established technique. However, complications from cannulating the foramen ovale (FO) have been reported because direct puncture of the FO is sometimes difficult. Here we report our experience with Dyna-CT-assisted PMC for TN in cannulating the FO and determining the position and volume of the balloon.
METHODS: Dyna-CT-assisted PMC was performed for image reconstruction in 16 cases. The optimal working projection was generated and further fluoroscopic data were used to determine the relationship of the needle with the FO during puncture. The balloon position and three-dimensional shape were verified with Dyna-CT during balloon compression and the balloon volume and puncture angle were also calculated. Patients' prognosis is discussed.
RESULTS: Dyna-CT allows quick, safe and easy cannulation of the FO. It provided three-dimensional images which were more elaborate than the classic 'pear shape' images for determining correct positioning in 16 cases. The volume of the inflated balloon ranged from 568.2 mm(3) to 891.4 mm(3) (average 769.5 mm(3)). The angle of introducing the cannula ranged from 15.32° to 35.48° rotation to the midline (average 25.18°) and 38.47°-51.89° angulation to the Reid line (average 46.17°). All the patients were pain-free after PMC. Four patients had resolvable masseter weakness and fine touch loss. No recurrence of TN was reported on follow-up.
CONCLUSIONS: Dyna-CT performed by digital subtraction angiography assists PMC in three ways: (1) the FO can be better visualized independent of the patient's position; (2) needle correction or insertion can be performed much more easily because of the direct fluoroscopic control; and (3) the needle position, balloon position, balloon configuration and the volume of the inflated balloon is more reliably determined. The use of Dyna-CT-assisted PMC has a low incidence of complications and a good prognosis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Balloon; CT; Cranial nerve; Technique

Mesh:

Year:  2013        PMID: 23904451     DOI: 10.1136/neurintsurg-2013-010676

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  5 in total

1.  Angular Relationship Between the Foramen Ovale and the Trigeminal Impression: Percutaneous Cannulation Trajectories for Trigeminal Neuralgia.

Authors:  Matthew J Zdilla; Scott A Hatfield; Kelsey R Mangus
Journal:  J Craniofac Surg       Date:  2016-11       Impact factor: 1.046

2.  Clinical Efficacy of a Spiral CT-Guided Balloon Compression Day-Surgery Operation for the Treatment of Trigeminal Neuralgia.

Authors:  Bing Xu; Zi-Pu Jia; Hao Ren; Lan Meng; Ying Shen; Tao Wang; Fang Luo; Rui Lv
Journal:  Front Neurol       Date:  2022-07-06       Impact factor: 4.086

3.  Orientation of the Foramen Ovale: An Anatomic Study With Neurosurgical Considerations.

Authors:  Matthew J Zdilla; Scott A Hatfield; Kennedy A McLean; Jillian M Laslo; Leah M Cyrus; H Wayne Lambert
Journal:  J Craniofac Surg       Date:  2016-01       Impact factor: 1.046

Review 4.  The Focus and New Progress of Percutaneous Balloon Compression for the Treatment of Trigeminal Neuralgia.

Authors:  Yinghua Xia; Gui Yu; Feixiang Min; Hui Xiang; Jinqing Huang; Jingxing Leng
Journal:  J Pain Res       Date:  2022-09-29       Impact factor: 2.832

5.  Continuous Intra-Arterial Blood Pressure Monitoring Improves the Efficiency of Percutaneous Balloon Compression of the Trigeminal Ganglion for Trigeminal Neuralgia.

Authors:  Yuchao Zuo; Dengpan Song; Yan Hu; Shengqi Zhao; Mingchu Zhang; Meng Wang; Fuyou Guo
Journal:  Pain Res Manag       Date:  2022-10-03       Impact factor: 2.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.